OncoLens

📍 Atlanta, United States🗓 Founded 2016👥 38 employees💰 Last funded Jan 2021
OncoLens is a powerful tool for the conduct of clinical cancer conferences and care treatment planning. Our oncology focus allows us to assist our clients in optimizing patient care and making the accreditation process easier. The OncoLens platform: • Creates and manages tumor board schedules • Integrates into EMR for efficient collection of data • Allows for uploading of images from a PC or smartphone • HIPAA compliant • Provides CoC/NAPBC/NAPRC accreditation documentation • Automatically screens for clinical trial eligibility • Facilitates remote meetings • Notifies team members of outstanding items • Real-time collaboration Benefits of implementing OncoLens: • Up to a 90% decrease in tumor board time • Expedited case review • Increased number of cases reviewed • Higher quality care • Increased participation in clinical trials • Documentation needed for CoC or NAPBC accreditation Let us help you streamline the cancer conference process. Contact us at support@oncolens.com for a demo.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in OncoLens?
OncoLens has 1 investors on record on gritt.io, 1 mid-stage.
When did OncoLens last raise funding?
The most recent investment in OncoLens recorded on gritt.io was in January 2021.
When was OncoLens founded?
OncoLens was founded in 2016.
What industry is OncoLens in?
OncoLens operates in Wellness and Fitness Services. Find similar Wellness and Fitness Services investors on gritt.io.
Where is OncoLens based?
OncoLens is headquartered in Atlanta, United States.